Cite
HARVARD Citation
Planchard, D. et al. (n.d.). Dabrafenib plus trametinib in patients with previously treated BRAFV600E-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial. Lancet oncology. 17 (7), pp. 984-993. [Online].